Kyowa Kirin Deal Strengthens Road Ahead For Kura’s Menin Contender

Beaten To Market But 1L Opportunity Beckons

 
• By Ian Haydock

Billion dollar-plus global deal with Japanese partner gives Kura's lead asset development impetus while adding to Kyowa Kirin's ambitions in hematological malignancies.

Acute myeloid leukemia a 3d-Render
AML with mutations the initial target of Kura/Kyowa Kirin deal • Source: Shutterstock

More from Deals

More from Scrip